TG Therapeutics, Inc. (TGTX)
29.70
-0.05
(-0.17%)
USD |
NASDAQ |
Dec 31, 11:28
TG Therapeutics Market Cap: 4.715B for Dec. 31, 2025
Market Cap Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Market Capitalization Definition
Market Capitalization measures the total value of a company based on their stock price multiplied by the shares outstanding. This metric is important because it gives you an idea of the size of a company, and how the size has changed over time. When studying companies from a relative basis, it would make sense to compare companies that have a similar market capitalization because factors like market share, economies of scale, and business models would also be similar.
Market Cap Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Market Cap Benchmarks
| Amgen, Inc. | 176.48B |
| Karyopharm Therapeutics, Inc. | 125.49M |
| Axsome Therapeutics, Inc. | 8.927B |
| Krystal Biotech, Inc. | 7.154B |
| Arcutis Biotherapeutics, Inc. | 3.562B |
Market Cap Related Metrics
| PE Ratio | 10.69 |
| PS Ratio | 9.026 |
| Price to Book Value | 7.765 |
| Price | 29.70 |
| Earnings Yield | 9.35% |
| Operating PE Ratio | 46.71 |
| Normalized PE Ratio | 10.69 |